The global myxoid liposarcoma treatment market size was valued at USD 33.53 billion in 2024 and is expected to reach USD 52.65 billion by 2032, at a CAGR of 5.80% during the forecast period
2 Views
top of page
New Product Alerts
Public·89 members
bottom of page